
1249: KBALL One
Hydroxychloroquine Lancet Study Retraction and Scientific Fraud
The Lancet and the New England Journal of Medicine retracted high-profile studies that had denounced hydroxychloroquine after independent reviewers could not verify the underlying data provided by the company Surgisphere. The retractions followed revelations that the data was likely fraudulent and the study lacked scientific credibility. Consequently, the World Health Organization has resumed its clinical trials of the drug for treating coronavirus.





